RIFABITE 400

Rifaximin Tablets 400mg

Targeted Non-Absorbable Antibiotic for Gastrointestinal Infections

Acts locally in the intestinal tract with minimal systemic absorption (<0.4%).
Broad spectrum bactericidal activity against enteric pathogens without systemic toxicity.
Significantly reduces intestinal ammonia production in patients with Hepatic Encephalopathy.
Reduces bloating, abdominal pain, and loose stools in Irritable Bowel Syndrome with Diarrhea (IBS-D).
High clinical safety and tolerability profile.

Composition

Rifaximin IP 400 mg

Packing

10 x 10 Tablets

Overview

Indications

Benefits

Dosage

Safety

Download

RIFABITE 400 provides targeted, non-systemic antimicrobial therapy within the gastrointestinal tract, ensuring exceptional clinical efficacy against intestinal pathogens with minimal risk of systemic adverse effects.

Gut-targeted action
Non-absorbable (<0.4%)
Highly effective in diarrhea & IBS-D
High safety & tolerability profile